Authors: Renier, G Desfaits, AC Serri, O

Citation: G. Renier et al., Effect of gliclazide on monocyte-endothelium interactions in diabetes, J DIABET C, 14(4), 2000, pp. 215-223

Authors: Patel, YC Ezzat, S Chik, CL Rorstad, OP Serri, O Ur, E Wilkins, GE

Citation: Yc. Patel et al., Guidelines for the diagnosis and treatment of acromegaly: a Canadian perspective, CLIN INV M, 23(3), 2000, pp. 172-187

Authors: Renier, G Desfaits, AC Serri, O

Citation: G. Renier et al., Gliclazide decreases low-density lipoprotein oxidation and monocyte adhesion to the endothelium, METABOLISM, 49(2), 2000, pp. 17-22

Authors: Desfaits, AC Serri, O Renier, G

Citation: Ac. Desfaits et al., Gliclazide reduces the induction of human monocyte adhesion to endothelialcells by glycated albumin, DIABET OB M, 1(2), 1999, pp. 113-120

Authors: Serri, O Renier, G

Citation: O. Serri et G. Renier, Antioxidant effects of gliclazide and soluble adhesion molecules in type 2diabetes - Response, DIABET CARE, 22(3), 1999, pp. 529-530

Authors: Serri, O St-Jacques, P Sartippour, M Renier, G

Citation: O. Serri et al., Alterations of monocyte function in patients with growth hormone (GH) deficiency: Effect of substitutive GH therapy, J CLIN END, 84(1), 1999, pp. 58-63